Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. CIPLA LIMITED (D.N.J. 2024)
✉ Email this page to a colleague
ASTRAZENECA PHARMACEUTICALS LP v. CIPLA LIMITED (D.N.J. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-07-31 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Robert Kirsch |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 7,449,464; 8,475,842; 8,859,562 | ||
| Link to Docket | External link to docket | ||
Details for ASTRAZENECA PHARMACEUTICALS LP v. CIPLA LIMITED (D.N.J. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-07-31 | 1 | Complaint | and belief, Cipla has not challenged U.S. Patent No. 7,449,464, which is listed in connection with LYNPARZA…of U.S. Patent No. 8,859,562 (“the ’562 patent”); U.S. Patent No. 11,970,530 (the “’530 patent”); U.S.…U.S. Patent No. 11,975,001 (the “’001 patent”); U.S. Patent No. 8,475,842 (“the ’842 patent”); and U.S.… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C…prior to the expiration of U.S. Patent No. 12,048,695 (the “’695 patent”). 2. Cipla notified | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
